Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Study Completion Date

May 31, 2011

Conditions

Relapsing Remitting Multiple Sclerosis (RRMS)Secondary Progressive Multiple Sclerosis (SPMS)

Interventions

DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

250 µg, sub-cutaneously, on alternate days

Trial Locations (1)

Many Locations